{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:57:23Z","timestamp":1785887843729,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.082","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T13:54:44Z","timestamp":1573221284000},"page":"868-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proteomics as a tool for live attenuated influenza vaccine characterisation"],"prefix":"10.1016","volume":"38","author":[{"given":"Amy","family":"Hawksworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Jayachander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabaz","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3673-9096","authenticated-orcid":false,"given":"Edward","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.082_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.10.082_b0010","first-page":"1","article-title":"Understanding Influenza","volume":"2018","author":"Hutchinson","year":"1836","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.vaccine.2019.10.082_b0015","unstructured":"Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;87:461-76."},{"key":"10.1016\/j.vaccine.2019.10.082_b0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2147\/IJWH.S47235","article-title":"Risk management of seasonal influenza during pregnancy: current perspectives","volume":"6","author":"Yudin","year":"2014","journal-title":"Int J Womens Health."},{"key":"10.1016\/j.vaccine.2019.10.082_b0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/spid.2002.125860","article-title":"Influenza vaccines in children","volume":"13","author":"Neuzil","year":"2002","journal-title":"Semin Pediatr Infect Dis."},{"key":"10.1016\/j.vaccine.2019.10.082_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/421274","article-title":"A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom General Practice Research Database","volume":"190","author":"Mangtani","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.082_b0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.vaccine.2019.10.082_b0040","unstructured":"Public Health England. Seasonal influenza vaccine uptake in children of primary school age: winter season 2016 to 2017. End of season report. 2017."},{"key":"10.1016\/j.vaccine.2019.10.082_b0045","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/prca.201500054","article-title":"Proteomic contributions to our understanding of vaccine and immune responses","volume":"9","author":"Galassie","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.vaccine.2019.10.082_b0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0264-410X(99)00183-8","article-title":"Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children","volume":"18","author":"Boyce","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vaccine.2015.11.010","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2\u201317 years of age in 2013\u20132014 in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0065","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.vaccine.2011.11.104","article-title":"The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0075","doi-asserted-by":"crossref","first-page":"ofx111","DOI":"10.1093\/ofid\/ofx111","article-title":"Live-attenuated influenza vaccine effectiveness in children From 2009 to 2015\u20132016: A systematic review and meta-analysis","volume":"4","author":"Caspard","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.082_b0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/jvi.2.5.409-414.1968","article-title":"Density gradient centrifugation of rubella virus","volume":"2","author":"McCombs","year":"1968","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2019.10.082_b0085","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/jvi.1.6.1207-1216.1967","article-title":"Purification of large quantities of influenza virus by density gradient centrifugation","volume":"1","author":"Reimer","year":"1967","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0090","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1038\/ncomms5816","article-title":"Conserved and host-specific features of influenza virion architecture","volume":"5","author":"Hutchinson","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.10.082_b0095","doi-asserted-by":"crossref","first-page":"e1000085","DOI":"10.1371\/journal.ppat.1000085","article-title":"Cellular proteins in influenza virus particles","volume":"4","author":"Shaw","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.10.082_b0100","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1038\/s41598-018-28700-7","article-title":"Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization","volume":"8","author":"McCraw","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.10.082_b0105","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1016\/j.vaccine.2006.05.084","article-title":"Inflexal V\u2013the influenza vaccine with the lowest ovalbumin content","volume":"24","author":"Kursteiner","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-10-141","article-title":"Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches","volume":"10","author":"Thompson","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2019.10.082_b0115","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.vaccine.2008.03.014","article-title":"Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry","volume":"26","author":"Williams","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0120","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/irv.12001","article-title":"Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines","volume":"7","author":"Getie-Kebtie","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2019.10.082_b0125","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1016\/j.vaccine.2012.05.036","article-title":"Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE","volume":"30","author":"Creskey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.082_b0130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 degrees c","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.10.082_b0135","doi-asserted-by":"crossref","first-page":"e1002993","DOI":"10.1371\/journal.ppat.1002993","article-title":"Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry","volume":"8","author":"Hutchinson","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.vaccine.2019.10.082_b0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat Meth"},{"key":"10.1016\/j.vaccine.2019.10.082_b0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4939-8678-1_5","article-title":"Purification and proteomics of influenza virions","volume":"1836","author":"Hutchinson","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0150","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.10.082_b0155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanhausser","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.082_b0160","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01248-16","article-title":"Complete and Incomplete Genome Packaging of Influenza A and B Viruses","volume":"7","author":"Nakatsu","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2019.10.082_b0165","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2009.73","article-title":"Uroplakins in urothelial biology, function, and disease","volume":"75","author":"Wu","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.vaccine.2019.10.082_b0170","doi-asserted-by":"crossref","first-page":"36826","DOI":"10.1038\/srep36826","article-title":"Novel High-throughput Approach for Purification of Infectious Virions","volume":"6","author":"James","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.10.082_b0175","article-title":"Egg-independent influenza vaccines and vaccine candidates","volume":"5","author":"Manini","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2019.10.082_b0180","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1271\/bbb.60.1503","article-title":"Binding of egg white proteins to viruses","volume":"60","author":"Tsuge","year":"1996","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.vaccine.2019.10.082_b0185","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jaci.2014.12.1925","article-title":"Safety of live attenuated influenza vaccine in atopic children with egg allergy","volume":"136","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaip.2014.08.008","article-title":"Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine","volume":"3","author":"Des Roches","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.vaccine.2019.10.082_b0195","article-title":"Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study","volume":"351","author":"Turner","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.082_b0200","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jaci.2010.03.009","article-title":"Ovalbumin content of influenza vaccines","volume":"125","author":"Li","year":"2010","journal-title":"J. Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0205","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1099\/vir.0.069542-0","article-title":"Influenza virus non-structural protein NS1: interferon antagonism and beyond","volume":"95","author":"Marc","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0210","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1038\/nm1218","article-title":"The process development challenge for a new vaccine","volume":"11","author":"Buckland","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.10.082_b0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4939-6412-3_5","article-title":"Scale-up of protein purification: downstream processing issues","volume":"1485","author":"Milne","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2019.10.082_b0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jchromb.2006.11.032","article-title":"Scale-up of monoclonal antibody purification processes","volume":"848","author":"Aldington","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:45Z","timestamp":1759401465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314719"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics as a tool for live attenuated influenza vaccine characterisation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}